{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T21:08:12Z","timestamp":1785186492712,"version":"3.55.0"},"reference-count":96,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,8,31]],"date-time":"2022-08-31T00:00:00Z","timestamp":1661904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,8,31]],"date-time":"2022-08-31T00:00:00Z","timestamp":1661904000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl. Stroke Res."],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1007\/s12975-022-01079-4","type":"journal-article","created":{"date-parts":[[2022,8,31]],"date-time":"2022-08-31T03:29:52Z","timestamp":1661916592000},"page":"631-639","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Cerebral Aneurysm and Interleukin-6: a Key Player in Aneurysm Generation and Rupture or Just One of the Multiple Factors?"],"prefix":"10.1007","volume":"14","author":[{"given":"Molly","family":"Monsour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide Marco","family":"Croci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basil E.","family":"Gr\u00fcter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Taussky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Marbacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siviero","family":"Agazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,31]]},"reference":[{"issue":"3","key":"1079_CR1","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1159\/000091655","volume":"26","author":"DL Labovitz","year":"2006","unstructured":"Labovitz DL, et al. Subarachnoid hemorrhage incidence among Whites, Blacks and Caribbean Hispanics: the Northern Manhattan Study. Neuroepidemiology. 2006;26(3):147\u201350.","journal-title":"Neuroepidemiology"},{"issue":"6","key":"1079_CR2","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1227\/01.neu.0000306090.30517.ae","volume":"61","author":"AM Shea","year":"2007","unstructured":"Shea AM, et al. Characteristics of nontraumatic subarachnoid hemorrhage in the United States in 2003. Neurosurgery. 2007;61(6):1131\u20137 (discussion 1137-8).","journal-title":"Neurosurgery"},{"issue":"7","key":"1079_CR3","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/S1474-4422(09)70126-7","volume":"8","author":"DJ Nieuwkamp","year":"2009","unstructured":"Nieuwkamp DJ, et al. Changes in case fatality of aneurysmal subarachnoid haemorrhage over time, according to age, sex, and region: a meta-analysis. Lancet Neurol. 2009;8(7):635\u201342.","journal-title":"Lancet Neurol"},{"issue":"6","key":"1079_CR4","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1227\/01.NEU.0000359317.15269.20","volume":"65","author":"MV Springer","year":"2009","unstructured":"Springer MV, et al. Predictors of global cognitive impairment 1 year after subarachnoid hemorrhage. Neurosurgery. 2009;65(6):1043\u201350 (discussion 1050-1).","journal-title":"Neurosurgery"},{"issue":"3","key":"1079_CR5","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1097\/ANA.0000000000000130","volume":"27","author":"S D'Souza","year":"2015","unstructured":"D\u2019Souza S. Aneurysmal subarachnoid hemorrhage. J Neurosurg Anesthesiol. 2015;27(3):222\u201340.","journal-title":"J Neurosurg Anesthesiol"},{"issue":"3","key":"1079_CR6","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1177\/1358863X18754693","volume":"23","author":"G Toth","year":"2018","unstructured":"Toth G, Cerejo R. Intracranial aneurysms: review of current science and management. Vasc Med. 2018;23(3):276\u201388.","journal-title":"Vasc Med"},{"issue":"1","key":"1079_CR7","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1056\/NEJM199701023360106","volume":"336","author":"WI Schievink","year":"1997","unstructured":"Schievink WI. Intracranial aneurysms. N Engl J Med. 1997;336(1):28\u201340.","journal-title":"N Engl J Med"},{"issue":"9378","key":"1079_CR8","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S0140-6736(03)13860-3","volume":"362","author":"DO Wiebers","year":"2003","unstructured":"Wiebers DO, et al. Unruptured intracranial aneurysms: natural history, clinical outcome, and risks of surgical and endovascular treatment. Lancet. 2003;362(9378):103\u201310.","journal-title":"Lancet"},{"issue":"4","key":"1079_CR9","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1179\/016164106X14973","volume":"28","author":"T Hashimoto","year":"2006","unstructured":"Hashimoto T, Meng H, Young WL. Intracranial aneurysms: links among inflammation, hemodynamics and vascular remodeling. Neurol Res. 2006;28(4):372\u201380.","journal-title":"Neurol Res"},{"issue":"2","key":"1079_CR10","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1093\/cvr\/cvq076","volume":"86","author":"AR Brasier","year":"2010","unstructured":"Brasier AR. The nuclear factor-kappaB-interleukin-6 signalling pathway mediating vascular inflammation. Cardiovasc Res. 2010;86(2):211\u20138.","journal-title":"Cardiovasc Res"},{"issue":"4","key":"1079_CR11","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.immuni.2004.07.020","volume":"21","author":"C Becker","year":"2004","unstructured":"Becker C, et al. TGF-beta suppresses tumor progression in colon cancer by inhibition of IL-6 trans-signaling. Immunity. 2004;21(4):491\u2013501.","journal-title":"Immunity"},{"issue":"9","key":"1079_CR12","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1038\/jcbfm.2012.84","volume":"32","author":"N Chalouhi","year":"2012","unstructured":"Chalouhi N, et al. Biology of intracranial aneurysms: role of inflammation. J Cereb Blood Flow Metab. 2012;32(9):1659\u201376.","journal-title":"J Cereb Blood Flow Metab"},{"key":"1079_CR13","doi-asserted-by":"publisher","first-page":"896283","DOI":"10.1155\/2015\/896283","volume":"2015","author":"DM Sawyer","year":"2015","unstructured":"Sawyer DM, et al. Inflammatory mediators in vascular disease: identifying promising targets for intracranial aneurysm research. Mediators Inflamm. 2015;2015:896283.","journal-title":"Mediators Inflamm"},{"key":"1079_CR14","doi-asserted-by":"publisher","first-page":"271582","DOI":"10.1155\/2012\/271582","volume":"2012","author":"N Chalouhi","year":"2012","unstructured":"Chalouhi N, et al. Cigarette smoke and inflammation: role in cerebral aneurysm formation and rupture. Mediators Inflamm. 2012;2012:271582.","journal-title":"Mediators Inflamm"},{"issue":"6","key":"1079_CR15","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1007\/s10753-013-9655-6","volume":"36","author":"HF Zhang","year":"2013","unstructured":"Zhang HF, et al. Expression of pro-inflammatory cytokines and the risk of intracranial aneurysm. Inflammation. 2013;36(6):1195\u2013200.","journal-title":"Inflammation"},{"key":"1079_CR16","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.wneu.2018.04.143","volume":"115","author":"F Signorelli","year":"2018","unstructured":"Signorelli F, et al. Hemodynamic stress, inflammation, and intracranial aneurysm development and rupture: a systematic review. World Neurosurg. 2018;115:234\u201344.","journal-title":"World Neurosurg"},{"issue":"1","key":"1079_CR17","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/S1474-4422(13)70263-1","volume":"13","author":"JP Greving","year":"2014","unstructured":"Greving JP, et al. Development of the PHASES score for prediction of risk of rupture of intracranial aneurysms: a pooled analysis of six prospective cohort studies. Lancet Neurol. 2014;13(1):59\u201366.","journal-title":"Lancet Neurol"},{"key":"1079_CR18","doi-asserted-by":"publisher","unstructured":"Simon M, Grote A. Interleukin 6 and aneurysmal subarachnoid hemorrhage. A narrative review. Int J Mol Sci. 2021;22(8):4133. https:\/\/doi.org\/10.3390\/ijms22084133.","DOI":"10.3390\/ijms22084133"},{"issue":"48","key":"1079_CR19","doi-asserted-by":"publisher","first-page":"3707","DOI":"10.1093\/eurheartj\/ehs354","volume":"34","author":"SC Harrison","year":"2013","unstructured":"Harrison SC, et al. Interleukin-6 receptor pathways in abdominal aortic aneurysm. Eur Heart J. 2013;34(48):3707\u201316.","journal-title":"Eur Heart J"},{"issue":"6","key":"1079_CR20","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1097\/01.shk.000029553.39081.ec","volume":"25","author":"CR Gomez","year":"2006","unstructured":"Gomez CR, et al. Aberrant acute-phase response in aged interleukin-6 knockout mice. Shock. 2006;25(6):581\u20135.","journal-title":"Shock"},{"issue":"4","key":"1079_CR21","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1182\/blood.V86.4.1243.bloodjournal8641243","volume":"86","author":"T Kishimoto","year":"1995","unstructured":"Kishimoto T, et al. Interleukin-6 family of cytokines and gp130. Blood. 1995;86(4):1243\u201354.","journal-title":"Blood"},{"issue":"3","key":"1079_CR22","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/(SICI)1098-1136(199703)19:3<227::AID-GLIA5>3.0.CO;2-W","volume":"19","author":"MA Klein","year":"1997","unstructured":"Klein MA, et al. Impaired neuroglial activation in interleukin-6 deficient mice. Glia. 1997;19(3):227\u201333.","journal-title":"Glia"},{"issue":"1","key":"1079_CR23","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.bbi.2004.02.003","volume":"19","author":"JD Morrow","year":"2005","unstructured":"Morrow JD, Opp MR. Sleep-wake behavior and responses of interleukin-6-deficient mice to sleep deprivation. Brain Behav Immun. 2005;19(1):28\u201339.","journal-title":"Brain Behav Immun"},{"issue":"6 Pt A","key":"1079_CR24","first-page":"1218","volume":"1863","author":"M Rothaug","year":"1863","unstructured":"Rothaug M, Becker-Pauly C. Rose-John S 2016 The role of interleukin-6 signaling in nervous tissue. Biochim Biophys Acta. 1863;1863(6 Pt A):1218\u201327.","journal-title":"Biochim Biophys Acta"},{"issue":"7","key":"1079_CR25","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1523\/JNEUROSCI.19-07-02535.1999","volume":"19","author":"M Penkowa","year":"1999","unstructured":"Penkowa M, et al. CNS wound healing is severely depressed in metallothionein I- and II-deficient mice. J Neurosci. 1999;19(7):2535\u201345.","journal-title":"J Neurosci"},{"issue":"6","key":"1079_CR26","doi-asserted-by":"publisher","first-page":"2627","DOI":"10.1084\/jem.183.6.2627","volume":"183","author":"H Hirota","year":"1996","unstructured":"Hirota H, et al. Accelerated nerve regeneration in mice by upregulated expression of interleukin (IL) 6 and IL-6 receptor after trauma. J Exp Med. 1996;183(6):2627\u201334.","journal-title":"J Exp Med"},{"issue":"7","key":"1079_CR27","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1111\/cns.13369","volume":"26","author":"J Brown","year":"2020","unstructured":"Brown J, et al. Spleen participation in partial MHC class II construct neuroprotection in stroke. CNS Neurosci Ther. 2020;26(7):663\u20139.","journal-title":"CNS Neurosci Ther"},{"key":"1079_CR28","doi-asserted-by":"publisher","unstructured":"Anthony S, et al.\u00a0Neuroinflammation, stem cells, and stroke. Stroke, 2022.\u00a0https:\/\/doi.org\/10.1161\/STROKEAHA.121.036948","DOI":"10.1161\/STROKEAHA.121.036948"},{"issue":"Suppl 2","key":"1079_CR29","doi-asserted-by":"publisher","first-page":"S325","DOI":"10.1111\/j.1532-5415.2010.02915.x","volume":"58","author":"M Kelly-Hayes","year":"2010","unstructured":"Kelly-Hayes M. Influence of age and health behaviors on stroke risk: lessons from longitudinal studies. J Am Geriatr Soc. 2010;58(Suppl 2):S325\u20138.","journal-title":"J Am Geriatr Soc"},{"issue":"6","key":"1079_CR30","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1093\/gerona\/61.6.575","volume":"61","author":"M Maggio","year":"2006","unstructured":"Maggio M, et al. Interleukin-6 in aging and chronic disease: a magnificent pathway. J Gerontol A Biol Sci Med Sci. 2006;61(6):575\u201384.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"8","key":"1079_CR31","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1089\/089771502320317087","volume":"19","author":"A Singhal","year":"2002","unstructured":"Singhal A, et al. Association between cerebrospinal fluid interleukin-6 concentrations and outcome after severe human traumatic brain injury. J Neurotrauma. 2002;19(8):929\u201337.","journal-title":"J Neurotrauma"},{"issue":"1","key":"1079_CR32","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1186\/s12883-020-01760-x","volume":"20","author":"KA Edwards","year":"2020","unstructured":"Edwards KA, et al. Interleukin-6 is associated with acute concussion in military combat personnel. BMC Neurol. 2020;20(1):209.","journal-title":"BMC Neurol"},{"key":"1079_CR33","doi-asserted-by":"publisher","first-page":"114009","DOI":"10.1016\/j.expneurol.2022.114009","volume":"351","author":"M Monsour","year":"2022","unstructured":"Monsour M, Ebedes D, Borlongan CV. A review of the pathology and treatment of TBI and PTSD. Exp Neurol. 2022;351:114009.","journal-title":"Exp Neurol"},{"issue":"6","key":"1079_CR34","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/0092-8674(90)90411-7","volume":"63","author":"M Hibi","year":"1990","unstructured":"Hibi M, et al. Molecular cloning and expression of an IL-6 signal transducer, gp130. Cell. 1990;63(6):1149\u201357.","journal-title":"Cell"},{"issue":"3","key":"1079_CR35","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/0092-8674(89)90438-8","volume":"58","author":"T Taga","year":"1989","unstructured":"Taga T, et al. Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130. Cell. 1989;58(3):573\u201381.","journal-title":"Cell"},{"issue":"5","key":"1079_CR36","doi-asserted-by":"publisher","first-page":"6561","DOI":"10.1007\/s13277-015-4529-1","volume":"37","author":"S Wang","year":"2016","unstructured":"Wang S, Zhang W. Genetic variants in IL-6\/JAK\/STAT3 pathway and the risk of CRC. Tumour Biol. 2016;37(5):6561\u20139.","journal-title":"Tumour Biol"},{"key":"1079_CR37","doi-asserted-by":"publisher","first-page":"604","DOI":"10.3389\/fimmu.2016.00604","volume":"7","author":"Y Luo","year":"2016","unstructured":"Luo Y, Zheng SG. Hall of fame among pro-inflammatory cytokines: interleukin-6 gene and its transcriptional regulation mechanisms. Front Immunol. 2016;7:604.","journal-title":"Front Immunol"},{"issue":"7","key":"1079_CR38","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1002\/j.1460-2075.1995.tb07128.x","volume":"14","author":"D Guschin","year":"1995","unstructured":"Guschin D, et al. A major role for the protein tyrosine kinase JAK1 in the JAK\/STAT signal transduction pathway in response to interleukin-6. EMBO J. 1995;14(7):1421\u20139.","journal-title":"EMBO J"},{"issue":"Pt 1","key":"1079_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/bj20030407","volume":"374","author":"PC Heinrich","year":"2003","unstructured":"Heinrich PC, et al. Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem J. 2003;374(Pt 1):1\u201320.","journal-title":"Biochem J"},{"issue":"12","key":"1079_CR40","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1038\/nrd1902","volume":"4","author":"BT Hennessy","year":"2005","unstructured":"Hennessy BT, et al. Exploiting the PI3K\/AKT pathway for cancer drug discovery. Nat Rev Drug Discov. 2005;4(12):988\u20131004.","journal-title":"Nat Rev Drug Discov"},{"issue":"2","key":"1079_CR41","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.cytogfr.2012.09.001","volume":"24","author":"P Ataie-Kachoie","year":"2013","unstructured":"Ataie-Kachoie P, Pourgholami MH, Morris DL. Inhibition of the IL-6 signaling pathway: a strategy to combat chronic inflammatory diseases and cancer. Cytokine Growth Factor Rev. 2013;24(2):163\u201373.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"1","key":"1079_CR42","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.expneurol.2012.03.019","volume":"236","author":"P Yang","year":"2012","unstructured":"Yang P, et al. IL-6 promotes regeneration and functional recovery after cortical spinal tract injury by reactivating intrinsic growth program of neurons and enhancing synapse formation. Exp Neurol. 2012;236(1):19\u201327.","journal-title":"Exp Neurol"},{"issue":"9","key":"1079_CR43","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1002\/glia.22689","volume":"62","author":"AJ Chucair-Elliott","year":"2014","unstructured":"Chucair-Elliott AJ, et al. Microglia-induced IL-6 protects against neuronal loss following HSV-1 infection of neural progenitor cells. Glia. 2014;62(9):1418\u201334.","journal-title":"Glia"},{"issue":"1","key":"1079_CR44","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1002\/glia.22739","volume":"63","author":"MP Hsu","year":"2015","unstructured":"Hsu MP, et al. Analysis of IL-6\/gp130 family receptor expression reveals that in contrast to astroglia, microglia lack the oncostatin M receptor and functional responses to oncostatin M. Glia. 2015;63(1):132\u201341.","journal-title":"Glia"},{"issue":"2","key":"1079_CR45","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/0304-3940(93)90396-3","volume":"160","author":"M Sawada","year":"1993","unstructured":"Sawada M, et al. Expression of cytokine receptors in cultured neuronal and glial cells. Neurosci Lett. 1993;160(2):131\u20134.","journal-title":"Neurosci Lett"},{"issue":"Pt 2","key":"1079_CR46","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1042\/bj3000281","volume":"300","author":"S Rose-John","year":"1994","unstructured":"Rose-John S, Heinrich PC. Soluble receptors for cytokines and growth factors: generation and biological function. Biochem J. 1994;300(Pt 2):281\u201390.","journal-title":"Biochem J"},{"key":"1079_CR47","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.ynstr.2016.03.003","volume":"4","author":"GE Hodes","year":"2016","unstructured":"Hodes GE, Menard C, Russo SJ. Integrating interleukin-6 into depression diagnosis and treatment. Neurobiol Stress. 2016;4:15\u201322.","journal-title":"Neurobiol Stress"},{"issue":"218","key":"1079_CR48","first-page":"1","volume":"2022","author":"M Monsour","year":"2022","unstructured":"Monsour M, Croci DM, Agazzi S. The role of IL-6 in TBI and PTSD, a potential therapeutic target? Clin Neurol Neurosurg. 2022;2022(218):1\u20136.","journal-title":"Clin Neurol Neurosurg"},{"issue":"1","key":"1079_CR49","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.ejvs.2006.08.002","volume":"33","author":"J Dawson","year":"2007","unstructured":"Dawson J, et al. Medical optimisation can reduce morbidity and mortality associated with elective aortic aneurysm repair. Eur J Vasc Endovasc Surg. 2007;33(1):100\u20134.","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"7","key":"1079_CR50","first-page":"1834","volume":"13","author":"Z Chen","year":"2020","unstructured":"Chen Z, et al. Regulatory mechanism of MiR-21 in formation and rupture of intracranial aneurysm through JNK signaling pathway-mediated inflammatory response. Int J Clin Exp Pathol. 2020;13(7):1834\u201341.","journal-title":"Int J Clin Exp Pathol"},{"key":"1079_CR51","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1146\/annurev.bioeng.10.061807.160439","volume":"10","author":"JD Humphrey","year":"2008","unstructured":"Humphrey JD, Taylor CA. Intracranial and abdominal aortic aneurysms: similarities, differences, and need for a new class of computational models. Annu Rev Biomed Eng. 2008;10:221\u201346.","journal-title":"Annu Rev Biomed Eng"},{"issue":"10","key":"1079_CR52","doi-asserted-by":"publisher","first-page":"e0185923","DOI":"10.1371\/journal.pone.0185923","volume":"12","author":"M Nishihara","year":"2017","unstructured":"Nishihara M, et al. The role of IL-6 in pathogenesis of abdominal aortic aneurysm in mice. PLoS One. 2017;12(10):e0185923.","journal-title":"PLoS One"},{"key":"1079_CR53","doi-asserted-by":"publisher","first-page":"392","DOI":"10.3389\/fphar.2020.00392","volume":"11","author":"D Yan","year":"2020","unstructured":"Yan D, et al. Bazedoxifene attenuates abdominal aortic aneurysm formation via downregulation of interleukin-6\/glycoprotein 130\/signal transducer and activator of transcription 3 signaling pathway in apolipoprotein E-knockout mice. Front Pharmacol. 2020;11:392.","journal-title":"Front Pharmacol"},{"issue":"5","key":"1079_CR54","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1016\/j.athoracsur.2015.05.009","volume":"100","author":"NH Pope","year":"2015","unstructured":"Pope NH, et al. Interleukin-6 receptor inhibition prevents descending thoracic aortic aneurysm formation. Ann Thorac Surg. 2015;100(5):1620\u20136.","journal-title":"Ann Thorac Surg"},{"issue":"1","key":"1079_CR55","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1161\/CIRCGENETICS.111.961235","volume":"5","author":"MO Chandesris","year":"2012","unstructured":"Chandesris MO, et al. Frequent and widespread vascular abnormalities in human signal transducer and activator of transcription 3 deficiency. Circ Cardiovasc Genet. 2012;5(1):25\u201334.","journal-title":"Circ Cardiovasc Genet"},{"issue":"2","key":"1079_CR56","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s41419-020-2326-2","volume":"11","author":"QY Wu","year":"2020","unstructured":"Wu QY, et al. A novel STAT3 inhibitor attenuates angiotensin II-induced abdominal aortic aneurysm progression in mice through modulating vascular inflammation and autophagy. Cell Death Dis. 2020;11(2):131.","journal-title":"Cell Death Dis"},{"issue":"1","key":"1079_CR57","doi-asserted-by":"publisher","first-page":"15208","DOI":"10.1038\/s41598-017-15207-w","volume":"7","author":"J Yu","year":"2017","unstructured":"Yu J, et al. Inhibition of phosphatidylinositol 3-kinease suppresses formation and progression of experimental abdominal aortic aneurysms. Sci Rep. 2017;7(1):15208.","journal-title":"Sci Rep"},{"key":"1079_CR58","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.ijcard.2020.03.072","volume":"312","author":"J Xiao","year":"2020","unstructured":"Xiao J, et al. Experimental abdominal aortic aneurysm growth is inhibited by blocking the JAK2\/STAT3 pathway. Int J Cardiol. 2020;312:100\u20136.","journal-title":"Int J Cardiol"},{"issue":"3","key":"1079_CR59","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1161\/ATVBAHA.112.300516","volume":"33","author":"M Romain","year":"2013","unstructured":"Romain M, et al. Overexpression of SOCS3 in T lymphocytes leads to impaired interleukin-17 production and severe aortic aneurysm formation in mice\u2014brief report. Arterioscler Thromb Vasc Biol. 2013;33(3):581\u20134.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1 Pt 2","key":"1079_CR60","first-page":"366","volume":"29","author":"KK Griendling","year":"1997","unstructured":"Griendling KK, et al. Angiotensin II signaling in vascular smooth muscle. New concepts Hypertension. 1997;29(1 Pt 2):366\u201373.","journal-title":"New concepts Hypertension"},{"issue":"12","key":"1079_CR61","doi-asserted-by":"publisher","first-page":"3637","DOI":"10.1172\/JCI38308","volume":"119","author":"BC Tieu","year":"2009","unstructured":"Tieu BC, et al. An adventitial IL-6\/MCP1 amplification loop accelerates macrophage-mediated vascular inflammation leading to aortic dissection in mice. J Clin Invest. 2009;119(12):3637\u201351.","journal-title":"J Clin Invest"},{"issue":"29","key":"1079_CR62","doi-asserted-by":"publisher","first-page":"12099","DOI":"10.1073\/pnas.0705268104","volume":"104","author":"A Kimura","year":"2007","unstructured":"Kimura A, Naka T, Kishimoto T. IL-6-dependent and -independent pathways in the development of interleukin 17-producing T helper cells. Proc Natl Acad Sci U S A. 2007;104(29):12099\u2013104.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"1079_CR63","doi-asserted-by":"publisher","first-page":"E746","DOI":"10.21037\/jtd.2016.06.37","volume":"8","author":"T Ijaz","year":"2016","unstructured":"Ijaz T, Tilton RG, Brasier AR. Cytokine amplification and macrophage effector functions in aortic inflammation and abdominal aortic aneurysm formation. J Thorac Dis. 2016;8(8):E746\u201354.","journal-title":"J Thorac Dis"},{"issue":"7","key":"1079_CR64","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1161\/ATVBAHA.112.301049","volume":"33","author":"X Ju","year":"2013","unstructured":"Ju X, et al. Interleukin-6-signal transducer and activator of transcription-3 signaling mediates aortic dissections induced by angiotensin II via the T-helper lymphocyte 17-interleukin 17 axis in C57BL\/6 mice. Arterioscler Thromb Vasc Biol. 2013;33(7):1612\u201321.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"1079_CR65","doi-asserted-by":"publisher","first-page":"e000065","DOI":"10.1161\/JAHA.112.000065","volume":"2","author":"AL Blomkalns","year":"2013","unstructured":"Blomkalns AL, et al. CD14 directs adventitial macrophage precursor recruitment: role in early abdominal aortic aneurysm formation. J Am Heart Assoc. 2013;2(2):e000065.","journal-title":"J Am Heart Assoc"},{"key":"1079_CR66","doi-asserted-by":"publisher","unstructured":"Strange F, Gruter BE, Fandino J, Marbacher S. Preclinical intracranial aneurysm models: a systematic review. Brain Sci. 2020;10(3):134. https:\/\/doi.org\/10.3390\/brainsci10030134.","DOI":"10.3390\/brainsci10030134"},{"key":"1079_CR67","doi-asserted-by":"publisher","unstructured":"Ikedo T, Minami M, Kataoka H, Hayashi K, Nagata M, Fujikawa R, Higuchi S, Yasui M, Aoki T, Fukuda M, Yokode M, Miyamoto S. Dipeptidyl peptidase-4 inhibitor anagliptin prevents intracranial aneurysm growth by suppressing macrophage infiltration and activation. J Am Heart Assoc. 2017;6(6):e004777. https:\/\/doi.org\/10.1161\/JAHA.116.004777.","DOI":"10.1161\/JAHA.116.004777"},{"issue":"1","key":"1079_CR68","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/s12974-016-0654-z","volume":"13","author":"DM Sawyer","year":"2016","unstructured":"Sawyer DM, et al. Lymphocytes influence intracranial aneurysm formation and rupture: role of extracellular matrix remodeling and phenotypic modulation of vascular smooth muscle cells. J Neuroinflammation. 2016;13(1):185.","journal-title":"J Neuroinflammation"},{"key":"1079_CR69","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jns.2015.11.037","volume":"360","author":"J Chen","year":"2016","unstructured":"Chen J, et al. Controlled release of osteopontin and interleukin-10 from modified endovascular coil promote cerebral aneurysm healing. J Neurol Sci. 2016;360:13\u20137.","journal-title":"J Neurol Sci"},{"key":"1079_CR70","doi-asserted-by":"publisher","unstructured":"Laurent D, Lucke-Wold B, Dodd WS, Martinez M, Chowdhury MAB, Hosaka K, Motwani K, Hoh B. Combination release of chemokines from coated coils to target aneurysm healing. J Neurointerv Surg. 2022 May 24:neurintsurg-2022-018710. https:\/\/doi.org\/10.1136\/neurintsurg-2022-018710.","DOI":"10.1136\/neurintsurg-2022-018710"},{"issue":"4","key":"1079_CR71","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1093\/neuros\/nyz220","volume":"86","author":"D Wajima","year":"2020","unstructured":"Wajima D, et al. Interleukin-6 promotes murine estrogen deficiency-associated cerebral aneurysm rupture. Neurosurgery. 2020;86(4):583\u201392.","journal-title":"Neurosurgery"},{"key":"1079_CR72","doi-asserted-by":"publisher","first-page":"6103","DOI":"10.2147\/JIR.S335618","volume":"14","author":"J Kaminska","year":"2021","unstructured":"Kaminska J, et al. IL-6 quotient (the ratio of cerebrospinal fluid IL-6 to serum IL-6) as a biomarker of an unruptured intracranial aneurysm. J Inflamm Res. 2021;14:6103\u201314.","journal-title":"J Inflamm Res"},{"issue":"9","key":"1079_CR73","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1161\/hq0901.094280","volume":"21","author":"DJ Brull","year":"2001","unstructured":"Brull DJ, et al. Interleukin-6 gene -174g>c and -572g>c promoter polymorphisms are strong predictors of plasma interleukin-6 levels after coronary artery bypass surgery. Arterioscler Thromb Vasc Biol. 2001;21(9):1458\u201363.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"1079_CR74","doi-asserted-by":"publisher","first-page":"714","DOI":"10.3171\/2009.8.JNS092","volume":"112","author":"P McColgan","year":"2010","unstructured":"McColgan P, Thant KZ, Sharma P. The genetics of sporadic ruptured and unruptured intracranial aneurysms: a genetic meta-analysis of 8 genes and 13 polymorphisms in approximately 20,000 individuals. J Neurosurg. 2010;112(4):714\u201321.","journal-title":"J Neurosurg"},{"issue":"8","key":"1079_CR75","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1136\/jnnp.2005.081976","volume":"77","author":"L Morgan","year":"2006","unstructured":"Morgan L, et al. The interleukin-6 gene -174G>C and -572G>C promoter polymorphisms are related to cerebral aneurysms. J Neurol Neurosurg Psychiatry. 2006;77(8):915\u20137.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1\u20132","key":"1079_CR76","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.jns.2011.03.036","volume":"306","author":"G Zhang","year":"2011","unstructured":"Zhang G, et al. Association of interleukin-6-572G\/C gene polymorphisms in the Cantonese population with intracranial aneurysms. J Neurol Sci. 2011;306(1\u20132):94\u20137.","journal-title":"J Neurol Sci"},{"issue":"7","key":"1079_CR77","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1089\/gtmb.2012.0004","volume":"16","author":"Y Liu","year":"2012","unstructured":"Liu Y, et al. The interleukin-6-572G\/C gene polymorphism and the risk of intracranial aneurysms in a Chinese population. Genet Test Mol Biomarkers. 2012;16(7):822\u20136.","journal-title":"Genet Test Mol Biomarkers"},{"issue":"1","key":"1079_CR78","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neulet.2008.04.077","volume":"440","author":"H Sun","year":"2008","unstructured":"Sun H, Zhang D, Zhao J. The interleukin-6 gene -572G>C promoter polymorphism is related to intracranial aneurysms in Chinese Han nationality. Neurosci Lett. 2008;440(1):1\u20133.","journal-title":"Neurosci Lett"},{"issue":"6","key":"1079_CR79","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1161\/STROKEAHA.114.007722","volume":"46","author":"K Shimada","year":"2015","unstructured":"Shimada K, et al. Protective role of peroxisome proliferator-activated receptor-gamma in the development of intracranial aneurysm rupture. Stroke. 2015;46(6):1664\u201372.","journal-title":"Stroke"},{"issue":"9","key":"1079_CR80","doi-asserted-by":"publisher","first-page":"105054","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.105054","volume":"29","author":"D Croci","year":"2020","unstructured":"Croci D, et al. Changes in the cerebrospinal fluid lipid profile following subarachnoid hemorrhage in a closed cranium model: correlations to cerebral vasospasm, neuronal cell death and interleukin-6 synthesis. A pilot study J Stroke Cerebrovasc Dis. 2020;29(9):105054.","journal-title":"A pilot study J Stroke Cerebrovasc Dis"},{"issue":"1","key":"1079_CR81","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s10143-021-01628-9","volume":"45","author":"DM Croci","year":"2022","unstructured":"Croci DM, et al. Preclinical and clinical role of interleukin-6 in the development of delayed cerebral vasospasm and neuronal cell death after subarachnoid hemorrhage: towards a potential target therapy? Neurosurg Rev. 2022;45(1):395\u2013403.","journal-title":"Neurosurg Rev"},{"issue":"5","key":"1079_CR82","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1007\/s12975-020-00880-3","volume":"12","author":"DM Croci","year":"2021","unstructured":"Croci DM, et al. Tocilizumab reduces vasospasms, neuronal cell death, and microclot formation in a rabbit model of subarachnoid hemorrhage. Transl Stroke Res. 2021;12(5):894\u2013904.","journal-title":"Transl Stroke Res"},{"key":"1079_CR83","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.2147\/NDT.S304394","volume":"17","author":"Y Yao","year":"2021","unstructured":"Yao Y, et al. Interleukin-6 in cerebrospinal fluid small extracellular vesicles as a potential biomarker for prognosis of aneurysmal subarachnoid haemorrhage. Neuropsychiatr Dis Treat. 2021;17:1423\u201331.","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"1","key":"1079_CR84","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1186\/s12974-016-0675-7","volume":"13","author":"A Niwa","year":"2016","unstructured":"Niwa A, et al. Interleukin-6, MCP-1, IP-10, and MIG are sequentially expressed in cerebrospinal fluid after subarachnoid hemorrhage. J Neuroinflammation. 2016;13(1):217.","journal-title":"J Neuroinflammation"},{"issue":"7","key":"1079_CR85","doi-asserted-by":"publisher","first-page":"e0132115","DOI":"10.1371\/journal.pone.0132115","volume":"10","author":"HW Kao","year":"2015","unstructured":"Kao HW, et al. Interleukin-6 as a prognostic biomarker in ruptured intracranial aneurysms. PLoS ONE. 2015;10(7):e0132115.","journal-title":"PLoS ONE"},{"issue":"12","key":"1079_CR86","doi-asserted-by":"publisher","first-page":"2971","DOI":"10.1161\/01.STR.31.12.2971","volume":"31","author":"K Fassbender","year":"2000","unstructured":"Fassbender K, et al. Endothelin-1 in subarachnoid hemorrhage: an acute-phase reactant produced by cerebrospinal fluid leukocytes. Stroke. 2000;31(12):2971\u20135.","journal-title":"Stroke"},{"issue":"4","key":"1079_CR87","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1136\/jnnp.70.4.534","volume":"70","author":"K Fassbender","year":"2001","unstructured":"Fassbender K, et al. Inflammatory cytokines in subarachnoid haemorrhage: association with abnormal blood flow velocities in basal cerebral arteries. J Neurol Neurosurg Psychiatry. 2001;70(4):534\u20137.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"1079_CR88","doi-asserted-by":"publisher","first-page":"245","DOI":"10.23736\/S0390-5616.16.03876-5","volume":"63","author":"D Croci","year":"2019","unstructured":"Croci D, et al. The relationship between IL-6, ET-1 and cerebral vasospasm, in experimental rabbit subarachnoid hemorrhage. J Neurosurg Sci. 2019;63(3):245\u201350.","journal-title":"J Neurosurg Sci"},{"issue":"4","key":"1079_CR89","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1161\/01.RES.0000115557.25127.8D","volume":"94","author":"S Wassmann","year":"2004","unstructured":"Wassmann S, et al. Interleukin-6 induces oxidative stress and endothelial dysfunction by overexpression of the angiotensin II type 1 receptor. Circ Res. 2004;94(4):534\u201341.","journal-title":"Circ Res"},{"issue":"3","key":"1079_CR90","doi-asserted-by":"publisher","first-page":"179","DOI":"10.2174\/157340308785160570","volume":"4","author":"T Hou","year":"2008","unstructured":"Hou T, et al. Roles of IL-6-gp130 signaling in vascular inflammation. Curr Cardiol Rev. 2008;4(3):179\u201392.","journal-title":"Curr Cardiol Rev"},{"issue":"12","key":"1079_CR91","doi-asserted-by":"publisher","first-page":"2576","DOI":"10.1161\/ATVBAHA.107.153080","volume":"27","author":"LI Schrader","year":"2007","unstructured":"Schrader LI, et al. IL-6 deficiency protects against angiotensin II induced endothelial dysfunction and hypertrophy. Arterioscler Thromb Vasc Biol. 2007;27(12):2576\u201381.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"1079_CR92","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s00701-020-04639-5","volume":"163","author":"K Obermueller","year":"2021","unstructured":"Obermueller K, et al. Frequency and risk factors for postoperative aneurysm residual after microsurgical clipping. Acta Neurochir. 2021;163(1):131\u20138.","journal-title":"Acta Neurochir"},{"issue":"3","key":"1079_CR93","doi-asserted-by":"publisher","first-page":"396","DOI":"10.3171\/jns.1999.91.3.0396","volume":"91","author":"CA David","year":"1999","unstructured":"David CA, et al. Late angiographic follow-up review of surgically treated aneurysms. J Neurosurg. 1999;91(3):396\u2013401.","journal-title":"J Neurosurg"},{"issue":"6","key":"1079_CR94","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.3171\/JNS\/2008\/108\/6\/1071","volume":"108","author":"G Lanzino","year":"2008","unstructured":"Lanzino G. Inflammation after embolization of intracranial aneurysms. J Neurosurg. 2008;108(6):1071\u20133.","journal-title":"J Neurosurg"},{"issue":"6","key":"1079_CR95","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/s41584-020-0419-z","volume":"16","author":"EH Choy","year":"2020","unstructured":"Choy EH, et al. Translating IL-6 biology into effective treatments. Nat Rev Rheumatol. 2020;16(6):335\u201345.","journal-title":"Nat Rev Rheumatol"},{"key":"1079_CR96","doi-asserted-by":"publisher","first-page":"1396398","DOI":"10.1155\/2017\/1396398","volume":"2017","author":"ML Morieri","year":"2017","unstructured":"Morieri ML, Passaro A, Zuliani G. Interleukin-6 \u201ctrans-signaling\u201d and ischemic vascular disease: the important role of soluble gp130. Mediators Inflamm. 2017;2017:1396398.","journal-title":"Mediators Inflamm"}],"container-title":["Translational Stroke Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12975-022-01079-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12975-022-01079-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12975-022-01079-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T04:08:12Z","timestamp":1692763692000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12975-022-01079-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,31]]},"references-count":96,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["1079"],"URL":"https:\/\/doi.org\/10.1007\/s12975-022-01079-4","relation":{},"ISSN":["1868-4483","1868-601X"],"issn-type":[{"value":"1868-4483","type":"print"},{"value":"1868-601X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,31]]},"assertion":[{"value":"16 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Ethics"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}